Related Experiment Video
Updated: Jan 10, 2026

Advanced 3D Liver Models for In vitro Genotoxicity Testing Following Long-Term Nanomaterial Exposure
Published on: June 5, 2020
3D Liver Models for Genotoxicity Testing
Gillian E Conway1, Ume-Kulsoom Shah1, Michael J Burgum1
1In Vitro Toxicology Group, Institute of Life Science, Swansea University Medical School, Swansea, Wales, UK.
Abstract:
Genotoxicity testing is a vital aspect of the safety assessment of new products (e.g., pharmaceuticals, foodstuffs, industrial chemicals). The ability of an agent to induce DNA damage is linked to long-term cancer risk as DNA damage is known to drive genome instability and carcinogenesis.There is much focus these days on the 3Rs (replacement, reduction, and refinement of animal testing), and in vitro tests are being sought to replace animal approaches. These new approach methodologies (NAMs) include the use of 3D human tissue models. Liver 3D models are particularly valuable as liver enzyme metabolism is sometimes difficult to recapitulate in vitro, and 3D liver models are known to express liver-specific enzymes at higher levels than 2D liver cells. Hence, the 3D liver models are more representative of human physiology.We present here detailed methodologies using 3D liver cell models to study DNA damage induction, specifically using the well-regarded micronucleus approach. We offer insights into the methods used and adaptations for nanomaterial assessment and other modifications possible with these approaches.

